jRCT1031250765尚未招募不适用
Prophylactic Study on Severe Skin Toxicity Associated with Enfortumab Vedotin: A Prospective Multicenter Study (PEACE Study (Prophylactic study of Enfortumab vedotin-Associated Cutaneous Events))
未提供0 个研究点目标入组 50 人开始时间: 待定
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
入排标准
- 年龄范围
- No limit 至 No limit（—）
- 性别
- All
入选标准
- •Patients aged 20 years or older who have provided written informed consent.
- •Patients diagnosed with advanced urothelial carcinoma.
- •Patients scheduled to receive treatment with enfortumab vedotin (EV).
- •Patients with good performance status (ECOG PS 0-2).
排除标准
- •Patients who have already started treatment with enfortumab vedotin (EV).
- •Patients with a history of hypersensitivity to zinc preparations.
- •Patients with severe comorbidities (e.g., uncontrolled diabetes, active infection).
- •Patients judged ineligible for the study by the investigator.
研究者
相似试验
尚未招募
不适用
Study to check the safety and effectiveness of the product on peopleCTRI/2025/09/094178Anivium technologies pvt. ltd36
尚未招募
3 期
Radomized controlled clinical study of shashilekhadi yoga in vicharchikaCTRI/2025/03/081981R A Podar Govt Ayu CollegeWorliMumbai80
已完成
不适用
Evaluation of Skin Safety of a Nano Urea emulsion Through 24-Hour Patch Testing in Healthy Individuals.CTRI/2024/11/077114CROM Clinical Research and Medical Tourism Pvt. Ltd. Division Nano Agro Technologies60
已完成
不适用
safety testing of test products using 24 hours patch test.CTRI/2025/11/097111ITC Life Sciences and Technology Centre24
尚未招募
不适用
Effect of product on pimple spotsCTRI/2024/08/072028Onesto Labs Pvt. Ltd.36